Volume 271, Number 43,
Issue of October 25, 1996
pp. 26739-26744
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
The Binding Protein for Globular Heads of Complement C1q,
gC1qR
FUNCTIONAL EXPRESSION AND CHARACTERIZATION AS A NOVEL
VITRONECTIN BINDING FACTOR
(Received for publication, January 22, 1996, and in revised form, July 17, 1996)
Boon-Leong
Lim
,
Kenneth B. M.
Reid
§
,
Berhane
Ghebrehiwet
¶
,
Ellinor I. B.
Peerschke
¶
,
Leonora A. E.
Leigh
§
and
Klaus T.
Preissner
From the
Department of Zoology, The University of
Hong Kong, Pokfulam, Hong Kong, § Medical Research Center
Immunochemistry Unit, Department of Biochemistry, University of Oxford,
Oxford OX1 3QU, United Kingdom, ¶ Departments of Medicine and
Pathology, State University of New York, Stony Brook, New York
11794-8161, and
Haemostasis Research Unit, Kerckhoff-Klinik,
Max-Planck-Institut, D-61231 Bad Nauheim, Germany
A binding protein for the globular
head domains of complement component C1q, designated gC1qR, recently
described to be present on vascular and blood cells (Ghebrehiwet, B.,
Lim, B.-L., Peerschke, E. I. B., Willis, A. C., and Reid, K. B. M. (1994) J. Exp. Med. 179, 1809-1821 was expressed in
recombinant form in bacteria to investigate its functional and
structural properties. The recombinant gC1qR was found to be functional
because tetramerization of the 24.3-kDa polypeptide occurred as
described for the native protein, and the binding of the ligand C1q by
recombinant gC1qR was indistinguishable from binding shown by gC1qR
isolated from Raji cells. Recombinant gC1qR immobilized to microspheres
was used to search for additional binding proteins unrelated to C1q.
Surprisingly, it was found that vitronectin or complexes containing
vitronectin were retained from plasma or serum, and subsequent analysis
revealed the specific binding of the ternary
vitronectin-thrombin-antithrombin complex to gC1qR. Because the
thrombin-antithrombin complex was unable to interact with gC1qR, direct
binding with vitronectin was investigated in a purified system. The
heparin binding multimeric form of vitronectin but not the plasma form
of vitronectin was found to bind specifically to gC1qR isolated from
Raji cell membrane as well as to recombinant gC1qR. This interaction
was saturable (KD ~20 nM) and
inhibitable by glycosaminoglycans such as heparin but not by
chondroitin sulfate. C1q and vitronectin did not compete with each
other for binding to gC1qR, and both ligands seem to interact with
different parts of the gC1qR because a truncated version of recombinant
gC1qR lacking the N-terminal 22-amino acid portion hardly interacted
with vitronectin but bound C1q as well as the intact gC1qR. These
findings establish gC1qR as a novel vitronectin-binding protein that
may participate in the clearance of vitronectin-containing complexes or
opsonized particles or cooperate with vitronectin in the inhibition of
complement-mediated cytolysis.